Intrinsic Value

Relmada Therapeutics, Inc. (RLMD)

$4.65

+0.06 (+1.31%)

Enterprise Value -
Net Debt -5.40
Equity Value -
Shares Outstanding 29.63
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt